Camponeschi, C.; De Carluccio, M.; Amadio, S.; Clementi, M.E.; Sampaolese, B.; Volonté, C.; Tredicine, M.; Romano Spica, V.; Di Liddo, R.; Ria, F.;
et al. S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis. Int. J. Mol. Sci. 2021, 22, 13558.
https://doi.org/10.3390/ijms222413558
AMA Style
Camponeschi C, De Carluccio M, Amadio S, Clementi ME, Sampaolese B, Volonté C, Tredicine M, Romano Spica V, Di Liddo R, Ria F,
et al. S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis. International Journal of Molecular Sciences. 2021; 22(24):13558.
https://doi.org/10.3390/ijms222413558
Chicago/Turabian Style
Camponeschi, Chiara, Maria De Carluccio, Susanna Amadio, Maria Elisabetta Clementi, Beatrice Sampaolese, Cinzia Volonté, Maria Tredicine, Vincenzo Romano Spica, Rosa Di Liddo, Francesco Ria,
and et al. 2021. "S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis" International Journal of Molecular Sciences 22, no. 24: 13558.
https://doi.org/10.3390/ijms222413558
APA Style
Camponeschi, C., De Carluccio, M., Amadio, S., Clementi, M. E., Sampaolese, B., Volonté, C., Tredicine, M., Romano Spica, V., Di Liddo, R., Ria, F., Michetti, F., & Di Sante, G.
(2021). S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis. International Journal of Molecular Sciences, 22(24), 13558.
https://doi.org/10.3390/ijms222413558